Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA

被引：0
|
作者：
Ricke, Brandon [1 ]
Shah, Kushal [1 ]
Salacz, Michael [1 ]
Camarata, Paul [1 ]
Lovick, Darren [2 ]
Peng, Warner [1 ]
Dolatkhah, Roya [1 ]
Sanaat, Zohreh [1 ]
Kimura, Kyle [1 ]
Bi, Danse [1 ]
Taylor, Sarah [1 ]
Esfandyari, Tuba [1 ]
Farassati, Faris [1 ]
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Univ Missouri, Sch Med, St Lukes Hosp, Kansas City, KS USA
来源：
NEURO-ONCOLOGY | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TR-01
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [31] EZH2 as a potential therapeutic target for gastrointestinal cancers
    Hashemi, Mehrdad
    Nazdari, Naghmeh
    Gholamiyan, Ghazaleh
    Paskeh, Mahshid Deldar Abad
    Jafari, Ali Moghadas
    Nemati, Fateme
    Khodaei, Elaheh
    Abyari, Ghazal
    Behdadfar, Nazanin
    Raei, Behnaz
    Raesi, Rasoul
    Nabavi, Noushin
    Hu, Peng
    Rashidi, Mohsen
    Taheriazam, Afshin
    Entezari, Malihe
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [32] Ezh2 Is A Novel Regulator Of Lung Fibrosis
    Guo, J.
    Sime, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Identification of novel EZH2 inhibitor scaffolds
    Espanel, X.
    Chene, L.
    Soude, A.
    Estevez, S.
    Adarbes, V.
    Loillier, B.
    Boubia, B.
    Masson, P.
    Montalbetti, C.
    Broqua, P.
    Fromond, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 191 - 191
  • [34] Identification of a Novel EZH2 Complex in Cancer
    Shinjo, Keiko
    Iijima, Kenta
    Suzuki, Miho
    Kaneko, Hiroki
    Kondo, Yutaka
    CANCER SCIENCE, 2021, 112 : 336 - 336
  • [35] Enhancer of Zeste Homologue 2 (EZH2) Expression Is Associated with Cell Proliferation in Medulloblastoma
    Shi, M.
    Qiu, J.
    Smith, T. W.
    Kilpatrick, D. L.
    Wang, W.
    MODERN PATHOLOGY, 2013, 26 : 418A - 418A
  • [36] Enhancer of Zeste Homologue 2 (EZH2) Expression Is Associated with Cell Proliferation in Medulloblastoma
    Shi, M.
    Qiu, J.
    Smith, T. W.
    Kilpatrick, D. L.
    Wang, W.
    LABORATORY INVESTIGATION, 2013, 93 : 418A - 418A
  • [37] Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
    Sherif Idris
    Cameron Lindsay
    Morris Kostiuk
    Colin Andrews
    David W. J. Côté
    Daniel A. O’Connell
    Jeffrey Harris
    Hadi Seikaly
    Vincent L. Biron
    Journal of Otolaryngology - Head & Neck Surgery, 45
  • [38] EZH2 as a mediator of treatment resistance in melanoma
    Tiffen, Jessamy C.
    Gallagher, Stuart J.
    Tseng, Hsin-Yi
    Filipp, Fabian V.
    Fazekas de St Groth, Barbara
    Hersey, Peter
    PIGMENT CELL & MELANOMA RESEARCH, 2016, 29 (05) : 500 - 507
  • [39] Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
    Idris, Sherif
    Lindsay, Cameron
    Kostiuk, Morris
    Andrews, Colin
    Cote, David W. J.
    O'Connell, Daniel A.
    Harris, Jeffrey
    Seikaly, Hadi
    Biron, Vincent L.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 45 : 1 - 7
  • [40] Inhibition of SIRT1 Increases EZH2 Protein Level and Enhances the Repression of EZH2 on Target Gene Expression
    Chih-chuan Liang
    ChineseMedicalSciencesJournal, 2011, 26 (02) : 77 - 84
12345